Daewoong Therapeutics , a medical-pharmaceutical R&D company
Daewoong Therapeutics R&D
Research & Development
Introducing Our Business Model
We research and develop personalized medicine in areas of oncology, ophthalmology, gastroenterology, metabolic diseases, dermatology, and veterinary medicines using novel delivery technologies such to improve the quality of life for humans and animals. Our liquid assets and recurring royalty payments from technology transfers allow a stable circulation of R&D work.
New Drug
Development
Precision medicine
Targeted Protein Degradation (PROTAC)
Synthetic Lethality
Latest modality and biomarker-based development
Drug Delivery Systems
Implementation of proprietary pipeline and DDS + new drug re-creation strategy using advanced drug delivery system platform technology
Microneedle
Nanocarrier Eyedrop Solution
Hyperconcentrated Spot-On Formulation
Ocular and Injectable Sustained-Release Implants
Supergenerics/505(b)(2) and CDO Services
High market demand-based product development
Financial stabilization via short-term technological fees and long-term royalty payments
Consignment and joint research with domestic partners
Technology transfer of incrementally modified drug(IMD) products
Veterinary Medicines
Open collaboration in product development and manufacturing processes
Application of advanced delivery technologies to optimize medication compliance
Various dosage forms including spot-on solutions, implants, and special feed
